ADDF-Harrington Scholar Award
April 23, 2021
Address
Chicago, IL 60612
Calendar
Download iCal FileADDF-HARRINGTON SCHOLAR AWARD
** Ph.D. or M.D. or equivalent required for eligibility. Open to researchers in the U.S., U.K. and Canada.
Call Opens: March 2
Letters of Intent (LOI) Due: April 23, 2021
Harrington Discovery Institute (HDI) and the Alzheimer’s Drug Discovery Foundation (ADDF) invite you to submit an LOI for the 2021 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and epigenetics. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are encouraged to apply. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.
Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.
Attached in a zip file is additional information on the ADDF-Harrington Scholar Award:
- One-Page Overview
- Frequently Asked Questions
- Grant Application Outline
Check out these short videos from Harrington Scholars.
To submit an online application, go to ADDF’s funding system and create an account.
Application questions? Contact grants@alzdiscovery.org or HDIQuestions@HarringtonDiscovery.org.
Scientific inquiries? Contact Meriel Owen, PhD, ADDF at mowen@alzdiscovery.org.
Date posted
Mar 2, 2021
Date updated
Mar 2, 2021